Patient characteristics | Patients (n = 27) |
---|---|
Patient demographics | |
Male | 19 (70.4%) |
Female | 8 (29.6%) |
Age (years), mean ± SD (range) | 43 ± 14.0 (27–70) |
Exposure history | |
Exposure to positive patients | 11 (40.7%) |
Unknown exposure | 16 (59.3%) |
Comorbid conditions | |
Diabetes | 6 (22.2%) |
Hypertension | 3 (11.1%) |
Renal failure | 3 (11.1%) |
COPD | 1 (3.7%) |
Liver disease | 1 (3.7%) |
Signs and symptoms | |
No obvious symptoms | 4 (14.8%) |
Fever | 19 (70.4%) |
Dry cough | 24 (88.9%) |
SOB | 6 (22.2%) |
Myalgia | 18 (66.6%) |
Sore throat | 16 (59.3%) |
Headache | 5 (18.5%) |
Diarrhea | 4 (14.8%) |
Vomit | 4 (14.8%) |
Nausea | 2 (7.4%) |
Laboratory test | |
C-reactive protein (mg/L; normal range 0–10) | |
Increased | 21 (77.8%) |
Decreased | 0 (0%) |
Normal | 4 (14.8%) |
Leukocytes (normal range 4–10 × 109/L) | |
Increased | 2 (7.4%) |
Decreased | 4 (14.8%) |
Normal | 21 (77.8%) |
Lymphocytes (normal range 20–40%) | |
Increased | 0 (0%) |
Decreased | 21 (77.8%) |
Normal | 6 (22.2%) |
Neutrophils (normal range 50–70%) | |
Increased | 19 (70.4%) |
Decreased | 0 (0%) |
Normal | 8 (29.6%) |